Streetbeat News

Price Targets

MYGN

Piper Sandler analyst John Peterson has initiated coverage on Myriad Genetics (NASDAQ:MYGN) with a Neutral rating and set a price target of $23 for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:36 am

MU

Barclays analyst Tom O'Malley has maintained an Overweight rating on Micron Technology (NASDAQ:MU) and increased the price target from $85 to $95, indicating a positive outlook on the stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:35 am

SPOT

Pivotal Research analyst Jeffrey Wlodarczak has upgraded Spotify Technology (NYSE:SPOT) from Hold to Buy and increased the price target from $170 to $265, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:32 am

GKOS

JP Morgan analyst Allen Gong has upgraded Glaukos (NYSE:GKOS) from Neutral to Overweight and increased the price target from $66 to $91, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:30 am

PODD

Baird analyst Jeff Johnson upgraded Insulet (NASDAQ:PODD) from Neutral to Outperform and increased the price target from $180 to $238, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 10:15 am

RCL

Tigress Financial analyst Ivan Feinseth has reaffirmed a Buy rating on Royal Caribbean Group (NYSE:RCL) and increased the price target from $139 to $155 as reported on December 20, 2023.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:56 am

RCL

Tigress Financial analyst Ivan Feinseth has reaffirmed a Buy rating on Royal Caribbean Group (NYSE:RCL) and increased the price target from $139 to $155.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:55 am

CPRX

Oppenheimer analyst Leland Gershell has initiated coverage on Catalyst Pharmaceuticals with an Outperform rating and set a price target of $30. The company is listed on NASDAQ under the ticker CPRX.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:44 am

CIFR

Canaccord Genuity analyst Joseph Vafi has reiterated a Buy rating on Cipher Mining (NASDAQ:CIFR) and maintained a price target of $5.5.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:39 am

ARGX

Raymond James analyst Danielle Brill has maintained a Strong Buy rating on argenx (NASDAQ:ARGX) but has reduced the price target from $580 to $520.

Portfolio Pulse from Benzinga Newsdesk

December 21, 2023 | 9:36 am